Medical University of Innsbruck at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Medical University of Innsbruck takes part in 4 sessions at ESMO 2026 in Madrid. Its sessions focus on gynaecological cancers, including antibody-drug conjugates and other targeted agents in platinum-resistant ovarian cancer, and cervical cancer from prevention to treatment. It also covers molecular diagnosis to guide targeted therapy in brain tumours.
| Organization | ESMO 2026 Attendance |
|---|---|
Medical University of Innsbruck Innsbruck, Austria | |
Public medical university in Innsbruck, Austria, which staffs the city's university hospital. | Satellite Sat Oct 24 18:35–18:55 The Emergence of Targeted Potency – ADCs in PROC Gynaecological cancers Satellite Sat Oct 24 19:35–19:50 Future Directions and Case-Based Application Gynaecological cancers Chair Sun Oct 25 14:45–16:15 Cervical cancer: From prevention to optimal therapy Gynaecological cancers Talk Mon Oct 26 08:30–08:50 Molecular diagnosis for targeted therapies in neuro-oncology Sarcoma, CNS, head & neck and rare cancers Abstract Mon Oct 26 17:54–18:06 Invited Discussant LBA12 Gynaecological cancersSarcoma, CNS, head & neck and rare cancers |
Instantly find 20 buyers from Medical University of Innsbruck
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction